77 related articles for article (PubMed ID: 2956371)
1. Changes in left ventricular anatomy and systemic hemodynamics induced by antihypertensive therapy with indenolol.
De Luca N; Ricciardelli B; Groothold G; Cuocolo A; Volpe M; Trimarco B
J Clin Hypertens; 1987 Jun; 3(2):125-34. PubMed ID: 2956371
[TBL] [Abstract][Full Text] [Related]
2. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
Sau F; Seguro C; Lai C; Orani E; Soro A; Onnis E; Cherchi A
Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
[TBL] [Abstract][Full Text] [Related]
3. Computerized echocardiographic study of left ventricular function and cardiodynamic investigation with a new antihypertensive agent (indenolol).
Venco A; Groothold G; Grandi A; Barzizza F; Corradi L; Negri F; Finardi G
Clin Ther; 1985; 7(3):347-56. PubMed ID: 3995529
[TBL] [Abstract][Full Text] [Related]
4. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
[TBL] [Abstract][Full Text] [Related]
5. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
[TBL] [Abstract][Full Text] [Related]
6. [Left ventricular function in essential hypertension during isoproterenol infusion].
Yasuda M; Oku H; Hirota K; Kajino H; Nishikimi T; Kawarabayashi T; Murai K; Yoshimura T; Takeuchi K; Takeda T
J Cardiogr; 1985 Sep; 15(3):761-71. PubMed ID: 2942608
[TBL] [Abstract][Full Text] [Related]
7. Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients treated with urapidil.
Arosio E; Pancera P; Sheiban I; Priante F; Ribul M; De Marchi S; Tonni S; Lechi A
J Hum Hypertens; 1996 Mar; 10(3):171-6. PubMed ID: 8733035
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
[TBL] [Abstract][Full Text] [Related]
9. Indenolol: a new antihypertensive agent: efficacy, toxicity, and hemodynamic effects in a crossover double-blind study with metoprolol.
Trimarco B; Cuocolo A; Groothold G; Ricciardelli B; De Luca N; Volpe M; Veniero AM; Condorelli M
J Clin Pharmacol; 1985; 25(5):328-36. PubMed ID: 4031109
[TBL] [Abstract][Full Text] [Related]
10. Reversal of left ventricular hypertrophy by terazosin in hypertensive patients.
Yasumoto K; Takata M; Yoshida K; Mikawa M; Tomoda F; Sasayama S
J Hum Hypertens; 1990 Feb; 4(1):13-8. PubMed ID: 1971654
[TBL] [Abstract][Full Text] [Related]
11. [Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
Sau F; Seguro C; Pargentino E
Cardiologia; 1994 Jul; 39(7):473-9. PubMed ID: 7982244
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular adaptation to cyclosporine-induced hypertension.
Ventura HO; Lavie CJ; Messerli FH; Valentino V; Smart FW; Stapleton DD; Ochsner JL
J Hum Hypertens; 1994 Apr; 8(4):233-7. PubMed ID: 8021902
[TBL] [Abstract][Full Text] [Related]
13. Systemic and renal effects of enalapril and its effects on cardiac mass.
Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878
[TBL] [Abstract][Full Text] [Related]
14. Effect of indenolol treatment on beta-adrenergic receptors of polymorphonucleates in essential hypertension.
Corradi L; Groothold G; Venco A; Mailland F; Negri F; Grandi A; Barzizza F; Finardi G
J Hypertens Suppl; 1986 Dec; 4(6):S137-40. PubMed ID: 2886569
[TBL] [Abstract][Full Text] [Related]
15. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
[TBL] [Abstract][Full Text] [Related]
16. Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension.
Trimarco B; Ricciardelli B; De Luca N; Volpe M; Veniero A; Cuocolo A; Condorelli M
Am J Cardiol; 1984 Mar; 53(6):791-6. PubMed ID: 6230921
[TBL] [Abstract][Full Text] [Related]
17. Cardiac effects of ACE inhibition.
Lund-Johansen P; Omvik P
J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S36-40. PubMed ID: 7507538
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
Malacco E; Mailland F; Bosisio E; Meroni R; Dagani R; Renesto E; Bevilacqua M
Eur J Clin Pharmacol; 1986; 30(2):157-60. PubMed ID: 3709639
[TBL] [Abstract][Full Text] [Related]
19. Effects of ACE inhibition on left ventricular dimensions and haemodynamics in systemic hypertension: a radionuclide and echocardiographic study.
Haznedaroglu IC; Erdem Y; Tokgözoglu L; Caglar M; Kes S; Sayinalp NM; Yörükan S
Cent Afr J Med; 1995 Apr; 41(4):118-23. PubMed ID: 7788682
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
